Cargando…
Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
Replication-competent retrovirus (RCR) vectors have been shown to achieve significantly enhanced tumor transduction efficiency and therapeutic efficacy in various cancer models. In the present study, we investigated RCR vector-mediated prodrug activator gene therapy for the treatment of malignant me...
Autores principales: | Kawasaki, Yoshiko, Tamamoto, Atsuko, Maeyama, Yoshihiro, Yamaoka, Norie, Terada, Nobuyuki, Okamura, Haruki, Kasahara, Noriyuki, Kubo, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159547/ https://www.ncbi.nlm.nih.gov/pubmed/21660062 http://dx.doi.org/10.1038/cgt.2011.25 |
Ejemplares similares
-
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018) -
Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model
por: Fujino, Hiroaki, et al.
Publicado: (2023) -
Do humans have replication-competent endogenous retroviruses?
por: Belshaw, Robert, et al.
Publicado: (2009) -
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model
por: Chen, Shih-Han, et al.
Publicado: (2020) -
Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018)